Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients With Type 2 Diabetes (T2DM): Rationale and Design

Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients With Type 2 Diabetes (T2DM): Rationale and Design

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2020.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fujiki, Shinya, Iijima, Kenichi, Okabe, Masaaki, Niwano, Shinichi, Tsujita, Kenichi, Naito, Shigeto, Ando, Kenji, Kusano, Kengo, Ritsushi Kato, Nitta, Junichi, Miura, Tetsuji, Mitsuhashi, Takeshi, Kazuomi Kario, Kondo, Yusuke, Ieda, Masaki, Hagiwara, Nobuhisa, Murohara, Toyoaki, Takahashi, Kazuyoshi, Tomita, Hirofumi, Yasuchika Takeishi, Toshihisa Anzai, Shimizu, Wataru, Watanabe, Masafumi, Morino, Yoshihiro, Kato, Takeshi, Tada, Hiroshi, Nakagawa, Yoshihisa, Yano, Masafumi, Maemura, Koji, Kimura, Takeshi, Yoshida, Hisako, Ota, Keiko, Tanaka, Takahiro, Kitamura, Nobutaka, Node, Koichi, Yoshifusa Aizawa, Ippei Shimizu, Izumi, Daisuke, Ozaki, Kazuyuki, Minamino, Tohru, Investigators, On Behalf Of The EMPA-ICD
Format: Video
Sprache:eng
Schlagworte:
Endocrinology
FOS: Clinical medicine
Medicine
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2020.
DOI:10.6084/m9.figshare.12827783